27
CPAP therapy in the Newborn Thrathip Kolatat M.D. Neonatal Intensive Care Unit Department of Pediatrics Faculty of Medicine Siriraj Hospital

CPAP therapy in the Newborn - · PDF fileCPAP therapy in the Newborn Thrathip Kolatat M.D. Neonatal Intensive Care Unit Department of Pediatrics Faculty of Medicine Siriraj Hospital

  • Upload
    hathien

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

CPAP therapyin the Newborn

Thrathip Kolatat M.D.

Neonatal Intensive Care Unit

Department of Pediatrics

Faculty of Medicine Siriraj Hospital

Continuous Positive Airway Pressure (CPAP)

CPAP

ll the application of positive the application of positive airway pressure airway pressure throughout the respiratory throughout the respiratory cycle during spontaneous cycle during spontaneous respirationrespiration

ll historyhistoryll Harrison 1968: described Harrison 1968: described

grunting in neonates as grunting in neonates as naturally producing endnaturally producing end--expiratory pressureexpiratory pressure

ll Gregory et al, 1971: Gregory et al, 1971: introduced the clinical use introduced the clinical use of distending pressure in of distending pressure in neonatesneonates

Physiologic effects of CPAP

ll pulmonary mechanicspulmonary mechanicsll cardiovascular stabilitycardiovascular stabilityll pulmonary vascular resistancepulmonary vascular resistance

Pulmonary effects

l decrease respiratory rate, tidal volume and minute volume

l regularization of respirationl increase FRC and thoracic gas volumel decrease lung compliance and

dynamic compliancel decrease total airway resistancel protective effect on surfactant

Control

+4 torr

2 3 4Age (days)

0

5

10

15

20FR

C (ml

/kg)

Effect of CPAP on FRC in the infants with RDS

CPAP (torr)4 8 12 16 200

100

200

300

Pa (t

orr)

o 2

Effect of different CPAP levels on PaO2

Cardiovascular effects

ll compromise venous return results in diminished cardiac compromise venous return results in diminished cardiac

outputoutput

ll depend on lung compliancedepend on lung compliance

ll sign and symptom: tachycardia, metabolic acidosis, sign and symptom: tachycardia, metabolic acidosis,

hypotension, decreased dynamic compliance, carbon dioxide hypotension, decreased dynamic compliance, carbon dioxide

retentionretention

ll decrease peripheral and regional blood flowdecrease peripheral and regional blood flow

ll decrease oxygen available to tissuedecrease oxygen available to tissue

ll increase extraincrease extra--pulmonary shunting secondary to an pulmonary shunting secondary to an

increase in pulmonary vascular resistanceincrease in pulmonary vascular resistance

Effects of CPAP

l Renal function

l decrease renal blood flow

l decrease urine output and urinary sodium excretion

l increase antidiuretic hormone and aldosterone

l Gastrointestinal function

l decrease gastrointestinal blood flow

l abdominal distention (CPAP belly syndrome)

l Intracranial pressure (head box CPAP) l increase intracranial pressure

l intracranial bleeding

Pressure volume curve

is divided into 3 regionsl region A: low lung

volume, low compliance and high resistance. The P/V slope is low

l region B: optimal lung volume and increases lung compliance

l region C: high lung volume, low lung compliance

0 5 10 15 20

Airway Generation

10,000

1000

100

10

2

Airw

ay Cross-S

ection in cm2

.08

.06

.04

.02

TurbulentHigh-VelocityFlow Region

LaminarLow-VelocityFlow Region

Res

ista

nce

(cm

H2O

/L p

er s

) NormalNewborn

Lung

HMD Lung

Pressure (cmH2O)V

olum

e (m

l)

Pressure- volume curve

Type of

CPAP

Clinical applications of CDP or CPAP

l respiratory distress syndrome

l meconium aspiration syndrome

l apnea of prematurity

l postoperative thoracotomy

l patent ductus arteriosus

l postoperative celosomia

l weaning patients from primary lung disease

l differentiation of primary lung disease from primary cardiac disease

l as adjunct to intermittent positive ventilation

l sleep apnea

l bronchomalacia

Clinical applications of CPAP

Side effectsUse

If lungs have normal compliancel over distentionl impede venous returnl air leak

l increasing lung volume in surfactant deficiencyl stabilizing areas of atelectasisl stabilizing obstructed airway

Medium (4-7 cm H2O)

l may be too low to maintain adequate lung volume or adequate oxygenation

l maintenance of lung volume in VLBW infantsl during weaningl during hyperventilation in PPHN

Side effectsUse

Low (2-3 cm H2O)

Side effectsUse

l air leakl decreased CL if over distendedl may impede venous returnl may increase PVRl CO2 retention

l tracheal or bronchial collapsel markedly decreased CL or severe obstructionl preventing white-out or re-establishing lung volume during ECHO

Ultrahigh (11-15 cm H2O)

l air leakl decreased CL if over distendedl may impede venous returnl may increase PVRl CO2 retention

l preventing alveolar collapse with poor CL and poor lung volumel improving distribution of ventilation

Side effectsUse

High (8-10 cm H2O)

Tracheomalacia

Optimal CPAP level

l balance between cardiac output and pulmonary blood flow

l congestive heart failure and pulmonary edema

4-day-old RDS and PDA

l pulmonary mechanics: resistance, compliance

l decreased compliancel increased resistance

BPD on 60% oxygen

l lung compliancel small A-a gradientl weak respiratory musclesl increased chest wall compliance

Small premature infant weaning off CPAP

l PaO2

l oxygen consumptionl oxygen delivery

l significant A-a gradientl rapid change compliance

Acute RDS

Optimal CPAP levelPhysiologyDisease

Clinical use of CPAP

l clinical indicationsl sign of atelectasis on

chest filml chest wall retractionl require FiO2>0.5l display rapidly

progressive lung disease

l initial pressure settingl nasal or nasopharyngeal:

6 cm H2Ol endotracheal: 4 cm H2O

l follow up and weaningl follow-up PaO2 within

15-20 min.l weaningl after oxygenation

was improvedl extubation from

CPAP 3-4 cm H2O

Nursing care of CPAP

l methodlnasallnasopharyngeallendotracheal tubel face mask

l componentsloxygenl temperature and humidity

lpressure

l nursing carelcontinuous care (oxygen, pressure)lcare of airway

l prevent obstructionl prevent irritation of nares

l skin carel abdominal distentionlNPO

Indication of CPAP

Atelectatic disordersl PaO2 below 50-60 mm Hg in FiO2>0.6

l recurrent apnea

Initial setupl CPAP 6 cm H2O

l increase 2-cm. increments q 15 min. to a max. of 10 cm H2O or 12 cm H2O

l increase FiO2 0.05-0.10 if PaO2<50 mm H2O

Respiratory distress syndrome

l improve survival rate, especially larger infants

l modify course of the disease l lower max.FiO2 required,

reduce total amount of time under O2 and the need for mechanical ventilation

Early CPAP in RDS

ll was proved to be more beneficial in the was proved to be more beneficial in the atelectaticatelectatic disease disease

ll lower peak pressure required in infants treated lower peak pressure required in infants treated with CPAPwith CPAP

ll enhance surfactant conservationenhance surfactant conservationll reduce the need for IMV by 20%, except infants reduce the need for IMV by 20%, except infants

with birth weight <1500 g.with birth weight <1500 g.ll improve mortality and decrease the incidence improve mortality and decrease the incidence

of BPDof BPDll prevent need for prolong intubation which prevent need for prolong intubation which

reduce the incidence of acquired subglottic reduce the incidence of acquired subglottic stenosis stenosis

Failure of CPAP therapy in RDS

l very low birth weight infantl late application of CPAPl severity of RDSl associated disease e.g. sepsis,

hypotensionl infants with severe degree of extra-

pulmonary shunt (Fox and coworkers, 1977)

CPAP in apnea of prematurity

l the application of low-level CPAP decrease the incidence of apnea of prematurity (compared to other forms of stimulation)l improve oxygenationl stimulation or inhibition of pulmonary reflexesl alveolar stabilizationl mechanical splinting of airway; reduce

supraglottic resistance in both inspiration and expiration

l some investigators recommended the early use of CPAP as a preventive measure of apnea of prematurity

CPAP in an infant with MAS

l pathology of meconiumaspirationl atelectasisl large airway obstructionl V/Q abnormalities

l application of low-to moderate level CPAPl resolution of atelectasisl stabilization of terminal

airwayl incidence of pneumothorax:

not increasedl precautions in case with PPHN

Adverse effects of CPAP

l pulmonary air leaksl type of CPAP l lung compliance l gestational age

l gastric dilation and rupture l hypotensionl increase pulmonary vascular resistancel chronic lung disease ?

Complication of face mask CPAP